ENDPOINTS NEWS1d
Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?
Novo Nordisk's CagriSema fell short of weight loss goals, causing 17% stock drop. Drug shows similar results to Eli Lilly's ...
ENDPOINTS NEWS2d
Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy
Amgen, Eli Lilly and UCB sued the federal government, claiming that several STD clinics getting drug discounts under the ...
ENDPOINTS NEWS2d
CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions
The Centers for Medicare and Medicaid Services on Friday released detailed but heavily redacted explanations of how it ...
ENDPOINTS NEWS2d
Fed­er­al ap­peals court says Te­va must delist Or­ange Book in­haler patents
The Federal Trade Commission is praising an appeals court decision calling for Teva to delist five inhaler patents from the ...
ENDPOINTS NEWS2d
Vi­a­tris' In­dia-based man­u­fac­tur­ing site blocked from ship­ping 11 gener­ic drugs to US
Generic drug firm Viatris announced Monday that one of its India-based manufacturing facilities has been placed on import ...
ENDPOINTS NEWS2d
Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra
An affiliate of Deerfield Management Company will acquire Singular Genomics Systems, ending a months-long competition between ...
ENDPOINTS NEWS2d
Sum­it­o­mo’s over­ac­tive blad­der drug adds an­oth­er in­di­ca­tion
Sumitomo Pharma’s oral treatment for overactive bladder symptoms has won an expanded label from the FDA, and is now approved ...